Back
Granite Real Estate Investment Trust Vs. Agios Pharmaceuticals Industry Stock Comparison
Buy
72
GRP.U
Granite Real Estate Investment Trust
Last Price:
51.93
Seasonality Move:
2.89%
Sell
1
AGIO
Agios Pharmaceuticals
Last Price:
38.94
Seasonality Move:
12.89%
Buy
72
Granite Real Estate Investment Trust (GRP.U)
is a Buy
Is Granite Real Estate Investment Trust a Buy, Sell or Hold?
- The current Granite Real Estate Investment Trust [GRP.U] share price is $51.75. The Score for GRP.U is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- GRP.U is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
1
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $38.17. The Score for AGIO is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
GRP.U Stock Price Chart
What is Granite Real Estate Investment Trust's stock price today?
-
The Granite Real Estate Investment Trust share price today is $51.75
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GRP.U is experiencing slight buying pressure.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $38.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing selling pressure, which indicates risk of future bearish movement.
GRP.U Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.67 | Sell |
| Relative Strength Index (14 RSI): | 43.25 | Sell |
| Chaikin Money Flow: | 620 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.05 - 54.13) | Sell |
| Bollinger Bands (100): | (52.24 - 58.12) | Sell |
AGIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.34 | Sell |
| Relative Strength Index (14 RSI): | 26.34 | Sell |
| Chaikin Money Flow: | -1550643 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.73 - 60.93) | Sell |
| Bollinger Bands (100): | (42.01 - 53.19) | Sell |
GRP.U Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.22 | Sell |
| 20-day SMA: | 52.87 | Sell |
| 50-day SMA: | 54.17 | Sell |
| 200-day SMA: | 53.73 | Sell |
| 8-day EMA: | 52.09 | Sell |
| 20-day EMA: | 52.76 | Sell |
| 50-day EMA: | 53.85 | Sell |
| 200-day EMA: | 54.3 | Sell |
AGIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.89 | Sell |
| 20-day SMA: | 54.55 | Sell |
| 50-day SMA: | 49.66 | Sell |
| 200-day SMA: | 41.9 | Sell |
| 8-day EMA: | 48.9 | Sell |
| 20-day EMA: | 52.35 | Sell |
| 50-day EMA: | 50.92 | Sell |
| 200-day EMA: | 42.82 | Sell |
Granite Real Estate Investment Trust Earnings Growth & GRP.U Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.79 per share, and an increase next year of $0.24 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $9.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.46 per share, and a decrease next year of $16.90 per share.
Granite Real Estate Investment Trust Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Agios Pharmaceuticals Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||